
What We’re Reading: Curbing Medical Debt Reports; Omicron Antibody Treatment; Middle, High School Tobacco Use
Starting July 1, credit-reporting giants will remove certain medical debts; AstraZeneca’s Evusheld was shown to reduce the viral load of subvariants BA.1, BA1.1, and BA.2; about 4% of middle school students and 13% of high school students use some type of tobacco product, according to a report.
Equifax, Experian, TransUnion to Remove Certain Medical Debts From Credit Reports
Credit-reporting giants Equifax, Experian and TransUnion announced Friday they will remove credit stains created by certain medical debts starting July 1, 2022.
AstraZeneca’s Evusheld Reduces Viral Load of Omicron Subvariants, Study Finds
AstraZeneca said Monday its COVID-19 antibody treatment, Evusheld, neutralized Omicron variants in an independent study,
Study Shows Millions of Middle, High School Students Use Tobacco Products
According to findings from the 2021 National Youth Tobacco Survey, 2.55 million middle school and high school students in the United States use some type of tobacco product, equating to about 4% of middle school students and 13% of high school students.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.